prof. dr. R.A.J.O. (Rudi) Dierckx

Professor

E-mail:
r.a.dierckx umcg.nl

Research

  1. 2013
  2. 2012
  3. Mees, G., Dierckx, R., Mertens, K., Vermeire, S., Van Steenkiste, M., Reutelingsperger, C., ... Van de Wiele, C. (2012). Tc-99m-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature. Journal of Nuclear Medicine, 53(3), 464-471. https://doi.org/10.2967/jnumed.111.095794
  4. Elsinga, P., van Waarde, A., Paans, A., & Dierckx, R. (2012). Epilog. In P. H. Elsinga, A. van Waarde, A. MJ. Paans, & R. AJO. Dierckx (Eds.), Trends on the Role of PET in Drug Development (pp. 751-761). Singapore: World Scientific Publishing.
  5. Teune, L. K., Mudali, D., Renken, R. J., de Jong, B. M., Segbers, M., Roerdink, J. B. T. M., ... Leenders, K. L. (2012). Glucose IMaging in ParkinsonismS. In 16th International Congress of Parkinson's Disease and Movement Disorders, Dublin, Ireland June 17-21
  6. Glaudemans, A. W. J. M., Dierckx, R., Otte, A., Pruim, J., & DEDEYN, PP. (2012). Good clinical practice and nuclear medicine. In Trends on the role of PET in drug development World Scientific Publishing.
  7. Elsinga, P., Paans, A., van Waarde, A., & Dierckx, R. (2012). Preface. In Trends on the Role of PET in Drug Development (pp. xxvii-xxx). Singapore: World Scientific Publishing.

ID: 255187